Dexamethasone / neomycin ophthalmic Pregnancy and Breastfeeding Warnings
Dexamethasone / neomycin ophthalmic is also known as: AK-Neo-Dex, Neo-Decadron, Neo-Decadron Ocumeter, Neo-Dex, Neo-Dexair
Dexamethasone / neomycin ophthalmic Pregnancy Warnings
Dexamethasone-neomycin ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have shown corticosteroids to be teratogenic in mice and rabbits following multiple dose topical ophthalmic application. There are no controlled data in human pregnancy. Dexamethasone-neomycin ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.
Dexamethasone / neomycin ophthalmic Breastfeeding Warnings
There are no data on the excretion of dexamethasone-neomycin ophthalmic into human milk. Topically applied steroids have been reported to be absorbed systemically. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.
References for pregnancy information
- "Product Information. NeoDecadron (dexamethasone-neomycin ophthalmic)." Merck & Co, Inc, West Point, PA.
References for breastfeeding information
- "Product Information. NeoDecadron (dexamethasone-neomycin ophthalmic)." Merck & Co, Inc, West Point, PA.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
